Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at mitoxantrone and low dose rituximab with chemotherapy for chronic lymphocytic leukaemia (ARCTIC)

Overview

Cancer types:

Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia

Status:

Results

Phase:

Phase 2

Details

This trial was for people with chronic lymphocytic leukaemia (CLL). It was for people who had not yet had treatment for their disease.

Recruitment start: 1 December 2009

Recruitment end: 26 September 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Peter Hillmen

Supported by

NIHR Health Technology Assessment (HTA) programme

NIHR Clinical Research Network: Cancer

The Leeds Teaching Hospitals NHS Trust

University of Leeds

Last reviewed: 22 January 2018

CRUK internal database number: 4560

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.